• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.美国 1988 年至 2008 年期间不受控制且明显的治疗抵抗性高血压。
Circulation. 2011 Aug 30;124(9):1046-58. doi: 10.1161/CIRCULATIONAHA.111.030189. Epub 2011 Aug 8.
2
Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.基于社区实践网络中诊室血压的明显治疗抵抗性高血压患者的最佳治疗方案的流行率。
Hypertension. 2013 Oct;62(4):691-7. doi: 10.1161/HYPERTENSIONAHA.113.01448. Epub 2013 Aug 5.
3
Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).美国的难治性高血压与心血管疾病死亡率:来自国家健康与营养检查调查(NHANES)的结果
BMC Nephrol. 2019 Apr 25;20(1):138. doi: 10.1186/s12882-019-1315-0.
4
Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.慢性肾脏病患者的炎症与貌似治疗抵抗性高血压
Hypertension. 2019 Apr;73(4):785-793. doi: 10.1161/HYPERTENSIONAHA.118.12358.
5
Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40-69 year olds.未控制和明显治疗抵抗性高血压:俄罗斯和挪威 40-69 岁人群的横断面研究。
BMC Cardiovasc Disord. 2020 Mar 13;20(1):135. doi: 10.1186/s12872-020-01407-2.
6
Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.伴有明显治疗抵抗或难以控制的高血压及 3 或 4 期慢性肾脏病患者的血压控制的真实世界影响。
Am J Hypertens. 2024 May 15;37(6):438-446. doi: 10.1093/ajh/hpae020.
7
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).抗高血压和降脂治疗预防心脏病发作试验(ALLHAT):治疗抵抗性高血压与心血管疾病和终末期肾病的发病率。
Hypertension. 2014 Nov;64(5):1012-21. doi: 10.1161/HYPERTENSIONAHA.114.03850. Epub 2014 Aug 4.
8
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.慢性肾脏病中貌似治疗抵抗性高血压的患病率及预后意义:慢性肾功能不全队列研究报告
Hypertension. 2016 Feb;67(2):387-96. doi: 10.1161/HYPERTENSIONAHA.115.06487. Epub 2015 Dec 28.
9
Prevalence of Apparent Treatment-Resistant Hypertension in the United States.美国显性治疗抵抗性高血压的流行情况。
Hypertension. 2019 Feb;73(2):424-431. doi: 10.1161/HYPERTENSIONAHA.118.12191.
10
Health care fragmentation and blood pressure control among adults taking antihypertensive medication.卫生保健碎片化与服用降压药的成年人血压控制
Am J Manag Care. 2022 Mar;28(3):108-115. doi: 10.37765/ajmc.2022.88837.

引用本文的文献

1
Efficacy and Safety of Aldosterone Synthase Inhibitors in Hypertension: A Systematic Review and Meta-Analysis.醛固酮合酶抑制剂治疗高血压的疗效与安全性:一项系统评价和Meta分析
Endocrinol Diabetes Metab. 2025 Sep;8(5):e70094. doi: 10.1002/edm2.70094.
2
Bioelectronic Therapeutics: A Revolutionary Medical Practice in Health Care.生物电子疗法:医疗保健领域的一种革命性医疗实践。
Bioelectricity. 2025 Mar 18;7(1):2-28. doi: 10.1089/bioe.2024.0039. eCollection 2025 Mar.
3
Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease.醛固酮靶向治疗:在顽固性高血压和慢性肾脏病中的早期应用
Eur Heart J. 2025 Jul 14;46(27):2618-2642. doi: 10.1093/eurheartj/ehaf225.
4
Triple Antihypertensive Medication Prediction Score After Intracerebral Hemorrhage (the TRICH Score).脑出血后三联抗高血压药物预测评分(TRICH评分)。
Neurology. 2025 May 13;104(9):e213560. doi: 10.1212/WNL.0000000000213560. Epub 2025 Apr 4.
5
Approaches and Challenges in Managing Treatment-Resistant Hypertension: A Case Report.难治性高血压管理中的方法与挑战:一例病例报告
Cureus. 2024 Dec 11;16(12):e75554. doi: 10.7759/cureus.75554. eCollection 2024 Dec.
6
Association between "Life's Essential 8" cardiovascular health and apparent treatment-resistant hypertension among US adults from the NHANES, 2005 to 2018.2005年至2018年美国国家健康与营养检查调查(NHANES)中美国成年人“生命基本八大要素”心血管健康与明显难治性高血压之间的关联。
Front Cardiovasc Med. 2024 Dec 13;11:1453563. doi: 10.3389/fcvm.2024.1453563. eCollection 2024.
7
Left ventricle remodeling by CMR in treated patients with primary aldosteronism and primary systemic arterial hypertension.采用心脏磁共振成像评估原发性醛固酮增多症合并原发性系统性动脉高血压患者经治疗后的左心室重构情况。
PLoS One. 2024 Dec 23;19(12):e0316140. doi: 10.1371/journal.pone.0316140. eCollection 2024.
8
Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement.难治性高血压的调查与管理:英国和爱尔兰高血压学会立场声明
J Hum Hypertens. 2025 Jan;39(1):1-14. doi: 10.1038/s41371-024-00983-6. Epub 2024 Dec 9.
9
Bioelectronic Medicines-A Novel Approach of Therapeutics in Current Epoch.生物电子药物——当代治疗学的一种新方法。
Curr Pharm Des. 2025;31(3):163-178. doi: 10.2174/0113816128326489240827100537.
10
GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review.基于胰高血糖素样肽-1(GLP-1)的疗法用于治疗超重或肥胖个体的难治性高血压:一项综述
EClinicalMedicine. 2024 Aug 15;75:102789. doi: 10.1016/j.eclinm.2024.102789. eCollection 2024 Sep.

本文引用的文献

1
Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.基于动态血压监测对 8295 例耐药性高血压患者的临床特征进行分类。
Hypertension. 2011 May;57(5):898-902. doi: 10.1161/HYPERTENSIONAHA.110.168948. Epub 2011 Mar 28.
2
Intensive blood-pressure control in hypertensive chronic kidney disease.高血压性慢性肾脏病的强化血压控制。
N Engl J Med. 2010 Sep 2;363(10):918-29. doi: 10.1056/NEJMoa0910975.
3
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.美国高血压的患病率、知晓率、治疗率和控制率趋势,1988-2008 年。
JAMA. 2010 May 26;303(20):2043-50. doi: 10.1001/jama.2010.650.
4
Effects of intensive blood-pressure control in type 2 diabetes mellitus.强化血压控制对 2 型糖尿病的影响。
N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.
5
Intensifying therapy for hypertension despite suboptimal adherence.尽管依从性欠佳仍强化高血压治疗。
Hypertension. 2009 Sep;54(3):524-9. doi: 10.1161/HYPERTENSIONAHA.109.133389. Epub 2009 Jul 6.
6
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.用于治疗但未控制的高血压患者校正的血浆肾素检测指导药物治疗算法:一项随机对照试验。
Am J Hypertens. 2009 Jul;22(7):792-801. doi: 10.1038/ajh.2009.63. Epub 2009 Apr 16.
7
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.贝那普利联合氨氯地平或氢氯噻嗪用于高危患者高血压的治疗
N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182.
8
Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004.1988 - 1994年至1999 - 2004年间美国成年人高血压患病率、知晓率、治疗率和控制率的趋势。
Hypertension. 2008 Nov;52(5):818-27. doi: 10.1161/HYPERTENSIONAHA.108.113357. Epub 2008 Oct 13.
9
Trends in obesity and abdominal obesity among hypertensive and nonhypertensive adults in the United States.美国高血压和非高血压成年人的肥胖及腹型肥胖趋势。
Am J Hypertens. 2008 Oct;21(10):1124-8. doi: 10.1038/ajh.2008.246. Epub 2008 Sep 4.
10
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.难治性高血压:诊断、评估与治疗。美国心脏协会高血压研究理事会专业教育委员会的科学声明。
Hypertension. 2008 Jun;51(6):1403-19. doi: 10.1161/HYPERTENSIONAHA.108.189141. Epub 2008 Apr 7.

美国 1988 年至 2008 年期间不受控制且明显的治疗抵抗性高血压。

Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.

机构信息

Department of Medicine, Medical University of South Carolina, 135 Rutledge Ave, 1230 RT, Charleston, SC 29425, USA.

出版信息

Circulation. 2011 Aug 30;124(9):1046-58. doi: 10.1161/CIRCULATIONAHA.111.030189. Epub 2011 Aug 8.

DOI:10.1161/CIRCULATIONAHA.111.030189
PMID:21824920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3210066/
Abstract

BACKGROUND

Despite progress, many hypertensive patients remain uncontrolled. Defining characteristics of uncontrolled hypertensives may facilitate efforts to improve blood pressure control.

METHODS AND RESULTS

Subjects included 13,375 hypertensive adults from National Health and Nutrition Examination Surveys (NHANESs) subdivided into 1988 to 1994, 1999 to 2004, and 2005 to 2008. Uncontrolled hypertension was defined as blood pressure ≥140/≥90 mm Hg and apparent treatment-resistant hypertension (aTRH) when subjects reported taking ≥3 antihypertensive medications. Framingham 10-year coronary risk was calculated. Multivariable logistic regression was used to identify clinical characteristics associated with untreated, treated uncontrolled on 1 to 2 blood pressure medications, and aTRH across all 3 survey periods. More than half of uncontrolled hypertensives were untreated across surveys, including 52.2% in 2005 to 2008. Clinical factors linked with untreated hypertension included male sex, infrequent healthcare visits (0 to 1 per year), body mass index <25 kg/m2, absence of chronic kidney disease, and Framingham 10-year coronary risk <10% (P<0.01). Most treated uncontrolled patients reported taking 1 to 2 blood pressure medications, a proxy for therapeutic inertia. This group was older, had higher Framingham 10-year coronary risk than patients controlled on 1 to 2 medications (P<0.01), and comprised 34.4% of all uncontrolled and 72.0% of treated uncontrolled patients in 2005 to 2008. We found that aTRH increased from 15.9% (1998-2004) to 28.0% (2005-2008) of treated patients (P<0.001). Clinical characteristics associated with aTRH included ≥4 visits per year, obesity, chronic kidney disease, and Framingham 10-year coronary risk >20% (P<0.01).

CONCLUSION

Untreated, undertreated, and aTRH patients have consistent characteristics that could inform strategies to improve blood pressure control by decreasing untreated hypertension, reducing therapeutic inertia in undertreated patients, and enhancing therapeutic efficiency in aTRH.

摘要

背景

尽管取得了进展,但许多高血压患者的血压仍未得到控制。确定未控制高血压患者的特征可能有助于改善血压控制。

方法和结果

研究对象包括来自国家健康和营养检查调查(NHANES)的 13375 名成年高血压患者,分为 1988 年至 1994 年、1999 年至 2004 年和 2005 年至 2008 年。未控制的高血压定义为血压≥140/≥90mmHg,当患者报告服用≥3 种降压药物时,出现明显的治疗抵抗性高血压(aTRH)。计算了弗雷明汉 10 年冠心病风险。多变量逻辑回归用于确定与所有 3 个调查期间未经治疗、用 1 至 2 种降压药物治疗但血压仍未控制以及 aTRH 相关的临床特征。超过一半的未控制高血压患者在所有调查中未经治疗,包括 2005 年至 2008 年的 52.2%。与未经治疗的高血压相关的临床因素包括男性、医疗保健就诊次数少(每年 0 至 1 次)、体重指数<25kg/m2、无慢性肾脏病和弗雷明汉 10 年冠心病风险<10%(P<0.01)。大多数接受治疗的未控制患者报告服用 1 至 2 种降压药物,这是治疗惰性的一个指标。该组年龄较大,与用 1 至 2 种药物控制血压的患者相比,弗雷明汉 10 年冠心病风险更高(P<0.01),在 2005 年至 2008 年期间,该组占所有未控制和 72.0%的治疗未控制患者。我们发现,治疗患者中 aTRH 的比例从 1998-2004 年的 15.9%增加到 2005-2008 年的 28.0%(P<0.001)。与 aTRH 相关的临床特征包括每年就诊≥4 次、肥胖、慢性肾脏病和弗雷明汉 10 年冠心病风险>20%(P<0.01)。

结论

未经治疗、治疗不足和 aTRH 的患者具有一致的特征,这些特征可能有助于通过减少未经治疗的高血压、减少治疗不足患者的治疗惰性以及提高 aTRH 的治疗效率来改善血压控制。